Search Results - "ERIKSTEIN, B"

RBC alloantibody prevalence and specificity in a Western Norwegian tertiary hospital by Erikstein, B. S., Hagen, K. G., Hervig, T.

“…SUMMARY Background and Objective Although several studies focus on red blood cell (RBC) alloantibody distribution in selected patient populations, few address…”
Get full text

Flotillins as regulators of ErbB2 levels in breast cancer by Pust, S, Klokk, T I, Musa, N, Jenstad, M, Risberg, B, Erikstein, B, Tcatchoff, L, Liestøl, K, Danielsen, H E, van Deurs, B, Sandvig, K

“…Amplification and overexpression of the receptor tyrosine kinase ErbB2 occur in up to 30% of human breast cancers, and high ErbB2 levels are correlated with…”
Get full text

Fulvestrant, Formerly ICI 182,780, Is as Effective as Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing After Prior Endocrine Treatment by HOWELL, A, ROBERTSON, J. F. R, QUARESMA ALBANO, J, ASCHERMANNOVA, A, MAURIAC, L, KLEEBERG, U. R, VERGOTE, I, ERIKSTEIN, B, WEBSTER, A, MORRIS, C

“…To compare the efficacy and tolerability of fulvestrant (formerly ICI 182,780) and anastrozole in postmenopausal women with advanced breast cancer progressing…”
Get full text

Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy by Wilking, N, Lidbrink, E, Wiklund, T, Erikstein, B, Lindman, H, Malmström, P, Kellokumpu-Lehtinen, P, Bengtsson, N-O, Söderlund, G, Anker, G, Wist, E, Ottosson, S, Salminen, E, Ljungman, P, Holte, H, Nilsson, J, Blomqvist, C, Bergh, J

“…Background: The purpose was to investigate adjuvant marrow-supportive high-dose chemotherapy compared with an equitoxicity-tailored comparator arm. Patients…”
Get full text

Quantitative Analysis of Chromosomal CGH in Human Breast Tumors Associates Copy Number Abnormalities with p53 Status and Patient Survival by Jain, Ajay N., Chin, Koei, Børresen-Dale, Anne-Lise, Erikstein, Bjorn K., Lonning, Per Eystein, Kaaresen, Rolf, Gray, Joe W.

“…We present a general method for rigorously identifying correlations between variations in large-scale molecular profiles and outcomes and apply it to…”
Get full text

Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells by Blomhoff, H K, Smeland, E B, Erikstein, B, Rasmussen, A M, Skrede, B, Skjønsberg, C, Blomhoff, R

“…In the present paper we demonstrate that retinol-retinol-binding protein and chylomicron remnant retinyl esters in concentrations normally found in human…”
Get full text

Adjuvant endocrine treatment (goserelin vs tamoxifen) in pre-menopausal patients with operable node positive stage II breast cancer. A prospective randomized national multicenter study by Söreide, J.A., Varhaug, J.E., Fjösne, H.E., Erikstein, B., Jacobsen, A.-B., Skovlund, E., Kvinnsland, S.

“…Aims: To evaluate possible differences in effect on time to recurrence and overall survival in node positive pre-menopausal breast cancer patients (age≤50…”
Get full text

Binucleation and polyploidization patterns in developmental and regenerative rat liver growth by Gerlyng, P, Abyholm, A, Grotmol, T, Erikstein, B, Huitfeldt, H S, Stokke, T, Seglen, P O

“…The hepatocellular binucleation rate, measured as the percentage of binuclear cells amongst newly formed bromodeoxyuridine-labelled and immunostained…”
Get more information

Effects of dose-intensive chemotherapy and radiotherapy on serum n-terminal proatrial natriuretic peptide in high-risk breast cancer patients by SUNDBY HALL, K, WIKLUND, T, ERIKSTEIN, B, HOLTE, H, KVALHEIM, G, HEEN SOMMER, H, ANDERSEN, A, SKOVLUND, E, BERGH, J, HALL, C

“…By using N-terminal proatrial natriuretic peptide (proANP) in serum as a marker of cardiac function, we compared the cardiac side effects of two intensive…”
Get full text

A new method for detachment of Dynabeads from positively selected B lymphocytes by Rasmussen, A M, Smeland, E B, Erikstein, B K, Caignault, L, Funderud, S

“…This paper describes a method for the detachment of immunomagnetic beads from positively selected human B lymphocytes. After rosetting of B cells using…”
Get more information

Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients by Bergh, J., Wiklund, T., Erikstein, B., Fornander, T., Bengtsson, N.-O., Malmström, P., Kellokumpu-Lehtinen, P., Anker, G., Bennmarker, H., Wilking, N.

“…Background: Conventional dosages of cytostatics in mg/m2will cause marked variations in systemic exposure, resulting in over- and under-treatment, at least…”
Get full text

Screening breast cancer patients for Norwegian ATM mutations by LAAKE, K, VU, P, ANDERSEN, T. I, ERIKSTEIN, B, KARESEN, R, LØNNING, P. E, SKOVLUND, E, BØRRESEN-DALE, A. L

“…483 Norwegian breast cancer patients were screened for six different ataxia telangiectasia mutated (ATM) mutations previously found to account for 83% of the…”
Get full text

Topoisomerase IIα Gene Amplification Predicts Favorable Treatment Response to Tailored and Dose-Escalated Anthracycline-Based Adjuvant Chemotherapy in HER-2/neu–Amplified Breast Cancer: Scandinavian Breast Group Trial 9401 by TANNER, Minna, ISOLA, Forma, WIKLUND, Tom, ERIKSTEIN, Björn, KELLOKUMPU-LEHTINEN, Pirkko, MALMSTRÖM, Per, WILKING, Nils, NILSSON, Jonas, BERGH, Jonas

“…Purpose Amplification of the HER-2/neu and topoisomerase IIα (TOP2A) genes has been linked to the effects of anthracyclines. Their role in predicting the…”
Get full text

Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes by Erikstein, B K, Smeland, E B, Blomhoff, H K, Funderud, S, Prydz, K, Lesslauer, W, Espevik, T

“…We have studied the expression of two different tumor necrosis factor receptors (TNFR; 55 kDa and 75 kDa) on resting and activated human peripheral blood B…”
Get more information

The retinoblastoma gene product is bound in the nucleus in early G1 phase by Stokke, T, Erikstein, B K, Smedshammer, L, Boye, E, Steen, H B

“…The product of the retinoblastoma susceptibility gene (pRB) exerts its growth-regulatory effects during the G1 phase of the cell cycle, where all pRB present…”
Get more information

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer by LØNNING, Per E, GEISLER, Jürgen, POLLI, Anna, MASSIMINI, Giorgio, KRAG, Lars E, ERIKSTEIN, Bjørn, BREMNES, Yngve, HAGEN, Anne I, SCHLICHTING, Ellen, LIEN, Ernst A, ØFJORD, Erik S, PAOLINI, Jolanda

“…To evaluate potential detrimental effects of exemestane on bone and lipid metabolism. Postmenopausal women with early breast cancer were randomly assigned to…”
Get full text

Interleukin-7 Differentiates a Subgroup of Acute Lymphoblastic Leukemias by Skj⊘nsberg, Cecilia, Erikstein, Bj⊘rn K., Smeland, Erlend B., Lie, Sverre O., Funderud, Steinar, Beiske, Klaus, Blomhoff, Heidi Kiil

“…The bone marrow stromal cell-derived growth factor interleukin-7 (IL-7) is known to stimulate growth of normal human B-cell precursors. In the present report,…”
Get full text

Cell cycle-specific expression and nuclear binding of DNA polymerase alpha by STOKKE, T, ERIKSTEIN, B, HOLTE, H, FUNDERUD, S, STEEN, H. B

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Use of size fractionation of in vitro-activated human B lymphocytes for studies of cell cycle-dependent growth regulation by Erikstein, B K, Schwarze, P, Blomhoff, H K, Funderud, S, Stokke, T, Smeland, E B

“…Cell cycle progression of in vitro-stimulated human B lymphocytes occurs asynchronously. In order to allow detailed studies of growth control in G1, B cells…”
Get more information

Basoluminal Carcinoma: A New Biologically and Prognostically Distinct Entity Between Basal and Luminal Breast Cancer by Laakso, Mervi, Tanner, Minna, Nilsson, Jonas, Wiklund, Tom, Erikstein, Björn, Kellokumpu-Lehtinen, Pirkko, Malmström, Per, Wilking, Nils, Bergh, Jonas, Isola, Jorma

“…Purpose: Breast carcinomas expressing basal epithelium cytokeratins constitute a tumor subgroup that is typically hormone receptor negative and shows a…”
Get full text